Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy

ClinicalTrials.gov ID: NCT04072380

Public ClinicalTrials.gov record NCT04072380. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 12:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is of an investigational drug called SUVN-G3031 (Samelisant) as a possible treatment for narcolepsy with cataplexy or narcolepsy without cataplexy. The main purpose of this study is to learn how well the study drug works and how safe the study drug is compared to placebo.

Study identification

NCT ID
NCT04072380
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Suven Life Sciences Limited
Industry
Enrollment
190 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 21, 2019 (Actual)
Primary completion
Jun 7, 2023 (Actual)
Completion
Jun 13, 2023 (Actual)
Last update posted
Jan 13, 2025

2019 – 2023

United States locations

U.S. sites
39
U.S. states
13
U.S. cities
33
Facility City State ZIP Site status
Sleep Disorders Center o f Alabama Birmingham Alabama 35213 —
Santa Monica Clinical Trials Los Angeles California 90025 —
Southern California Institute for Respiratory Diseases, Inc. Los Angeles California 90048-6138 —
Pacific Research Network, Inc. San Diego California 92103 —
SDS Clinical Trials Inc. Santa Ana California 92705 —
Meris Clinical Research Brandon Florida 33511 —
Teradan Clinical Trials Brandon Florida 33511 —
St. Francis Medical Institute Clearwater Florida 33765 —
PDS Research Kissimmee Florida 34741 —
Sleep Medicine Specialists of South Florida, PA Miami Florida 33126 —
Ivetmar Medical Group, LLC Miami Florida 33155 —
Florida Pediatric Research Institute Winter Park Florida 32789 —
Florida Pulmonary Research Institute, LLC Winter Park Florida 32789 —
NeuroTrials Research Inc Atlanta Georgia 30342 —
The Neuro Center Gainesville Georgia 30501 —
IACT Health Lawrenceville Georgia 30045 —
Sleep Practitioners, LLC Macon Georgia 31210 —
IACT Health Rincon Georgia 31326 —
Clinical Research Institute Stockbridge Georgia 30281 —
Helene A. Emsellem, MD PC Chevy Chase Maryland 20815 —
Bronson Sleep Health Portage Michigan 49024 —
Clinical Neurophysiology Services Sterling Heights Michigan 48314 —
St Lukes Hospital, Sleep Medicine & Research Center Chesterfield Missouri 63017 —
Clayton Sleep Institute St Louis Missouri 63123 —
Research Carolina Elite Denver North Carolina 28078 —
Clinical Research of Gastonia Gastonia North Carolina 28054 —
Ohio Sleep Medicine Institute Canton Ohio 44718 —
CTI Clinical Research Center Cincinnati Ohio 45212 —
Intrepid Research, LLC Cincinnati Ohio 45245 —
Cleveland Clinic, Sleep Disorders Center Cleveland Ohio 44195 —
Ohio Sleep Medicine Institute Dublin Ohio 43017 —
Respiratory Specialists Wyomissing Pennsylvania 19610 —
Medical University of South Carolina Charleston South Carolina 29425 —
Bogan Sleep Consultants Columbia South Carolina 29201 —
Lowcountry Lung Critical Care North Charleston South Carolina 29406 —
FutureSearch Trials of Neurology Austin Texas 78731 —
Sleep Therapy & Research Center San Antonio Texas 78229 —
Roadrunner Research San Antonio Texas 78249 —
Children's Hospital of the King's Daughters Norfolk Virginia 23507 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04072380, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 13, 2025 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04072380 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →